TY  - GEN

T1  - Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials

T2  - Research Square Platform LLC

UR  - http://dx.doi.org/10.21203/rs.3.rs-2205394/v1

PY  - 2022/12/02

AU  - Rugo HS

AU  - Poznak CHV

AU  - Neven P

AU  - Danielewicz I

AU  - Lee SC

AU  - Campone M

AU  - Chik JYK

AU  - Alonso EV

AU  - Naume B

AU  - Brain E

AU  - Siegel JM et al

ED  - 

DO  - DOI: 10.21203/rs.3.rs-2205394/v1

Y2  - 2025/10/10

ER  -